Keywords
Curation
Ncbi
Racine
Curation
Checkpoint
Ncbi
Racine
Ncbi
Exploration
Accueil
Racine
Racine

Serveur d'exploration sur les pandémies grippales - Curation (Ncbi)

Index « Keywords » - entrée « Influenza Vaccines (chemistry) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Influenza Vaccines (chemical synthesis) < Influenza Vaccines (chemistry) < Influenza Vaccines (classification)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 13.
Ident.Authors (with country if any)Title
000218 (2005) Peter Pushko [États-Unis] ; Terrence M. Tumpey ; Fang Bu ; John Knell ; Robin Robinson ; Gale SmithInfluenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice.
000E25 (2010) Vinay Saluja [Pays-Bas] ; Wouter L J. Hinrichs ; Henderik W. FrijlinkDried influenza vaccines: over the counter vaccines.
000E37 (2011) Alexander K. Andrianov [États-Unis] ; Daniel P. Decollibus ; Alexander Marin ; Ashley Webb ; Yolanda Griffin ; Richard J. WebbyPCPP-formulated H5N1 influenza vaccine displays improved stability and dose-sparing effect in lethal challenge studies.
001270 (2012) Tracie L. Williams [États-Unis] ; James L. Pirkle ; John R. BarrSimultaneous quantification of hemagglutinin and neuraminidase of influenza virus using isotope dilution mass spectrometry.
001377 (2012) Jesse Bodle ; Erin E. Verity ; Chi Ong ; Kirsten Vandenberg ; Robert Shaw ; Ian G. Barr ; Steven RockmanDevelopment of an enzyme‐linked immunoassay for the quantitation of influenza haemagglutinin: an alternative method to single radial immunodiffusion
001419 (2012) Joanne M. Langley [Canada] ; Dennis Reich ; Naresh Aggarwal ; David Connor ; Marc H. Lebel ; Anil Gupta ; Hartley Garfield ; Ping Li ; Anu Madan ; David W. VaughnRandomized, multicenter trial of a single dose of AS03-adjuvanted or unadjuvanted H1N1 2009 pandemic influenza vaccine in children 6 months to <9 years of age: safety and immunogenicity.
001959 (2015) Hang Sik Roh [Corée du Sud] ; Hye Min Song [Corée du Sud] ; Bo Reum Yun [Corée du Sud] ; Hyun Kyung Kang [Corée du Sud] ; Keum Suk Choi [Corée du Sud] ; Yun Ju Park [Corée du Sud] ; Dong Sub Kim [Corée du Sud] ; Seung Hee Kim [Corée du Sud] ; In Pil Mo [Corée du Sud] ; Beum-Soo An [Corée du Sud] ; Chi Young Ahn [Corée du Sud]A hemagglutinin quantification method for development of an influenza pandemic vaccine using size exclusion high performance liquid chromatography.
001A58 (2015) Julie Medina [France] ; Houda Boukhebza [France] ; Amélie De Saint Jean [France] ; Régis Sodoyer [France] ; Isabelle Legastelois [France] ; Catherine Moste [France]Optimization of influenza A vaccine virus by reverse genetic using chimeric HA and NA genes with an extended PR8 backbone.
001A93 (2015) Milan Sencanski ; Draginja Radosevic ; Vladimir Perovic ; Branislava Gemovic ; Maja Stanojevic ; Nevena Veljkovic ; Sanja Glisic [Serbie]Natural Products as Promising Therapeutics for Treatment of Influenza Disease.
001B84 (2016) Rahnuma Wahid [États-Unis] ; Renee Holt [États-Unis] ; Richard Hjorth [États-Unis] ; Francesco Berlanda Scorza [États-Unis]Chemistry, manufacturing and control (CMC) and clinical trial technical support for influenza vaccine manufacturers.
001C47 (2017) Jihyun Yang [Corée du Sud] ; Sang-Mu Shim [Corée du Sud] ; Thi Quyen Nguyen [Corée du Sud] ; Eun-Ha Kim [Corée du Sud] ; Kwang Kim [Corée du Sud] ; Yong Taik Lim [Corée du Sud] ; Moon-Hee Sung [Corée du Sud] ; Richard Webby [États-Unis] ; Haryoung Poo [Corée du Sud]Poly-γ-glutamic acid/chitosan nanogel greatly enhances the efficacy and heterosubtypic cross-reactivity of H1N1 pandemic influenza vaccine
001E20 (2018) Jack Ferdman ; Giuseppe Palladino ; Hua-Xin Liao ; M. Anthony Moody ; Thomas B. Kepler ; Giuseppe Del Giudice ; Philip R. Dormitzer ; Stephen C. Harrison ; Ethan C. Settembre ; Pirada SuphaphiphatIntra-Seasonal Antibody Repertoire Analysis of a Patient Immunized with an MF59®-adjuvanted Pandemic 2009 H1N1 Vaccine
001E56 (2018) Vladislav Victorovich Khrustalev [Biélorussie] ; Tatyana Aleksandrovna Khrustaleva [Biélorussie] ; Larisa Valentinovna Kordyukova [Russie]Selection and structural analysis of the NY25 peptide - A vaccine candidate from hemagglutinin of swine-origin Influenza H1N1.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Influenza Vaccines (chemistry)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Influenza Vaccines (chemistry)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PandemieGrippaleV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Influenza Vaccines (chemistry)
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021